Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
6.17
-0.08 (-1.28%)
Nov 20, 2024, 4:00 PM EST - Market closed

Adverum Biotechnologies Revenue

Adverum Biotechnologies had revenue of $1.00M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $1.00M, down -72.22% year-over-year. In the year 2023, Adverum Biotechnologies had annual revenue of $3.60M.

Revenue (ttm)
$1.00M
Revenue Growth
-72.22%
P/S Ratio
105.43
Revenue / Employee
$8,264
Employees
121
Market Cap
128.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.60M--
Dec 31, 2022---
Dec 31, 20217.50M--
Dec 31, 2020---
Dec 31, 2019250.00K-1.36M-84.49%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 243.57M
Compugen 59.85M
Elutia 24.78M
Seer, Inc. 14.61M
Cardiff Oncology 688.00K
Zentek 29.13K
Inhibikase Therapeutics 1.00
Revenue Rankings